Skip to main content

Peer Review reports

From: Underexpression of Deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma

Original Submission
1 Jan 2008 Submitted Original manuscript
20 Jan 2008 Reviewed Reviewer Report - yick pang Ching
22 Jan 2008 Reviewed Reviewer Report - Nicholas Popescu
28 Jan 2008 Reviewed Reviewer Report - Tsung-Hui Hu
2 Apr 2008 Author responded Author comments - Li xiaorong
Resubmission - Version 2
2 Apr 2008 Submitted Manuscript version 2
3 Apr 2008 Reviewed Reviewer Report - Nicholas Popescu
8 Apr 2008 Reviewed Reviewer Report - yick pang Ching
15 Apr 2008 Reviewed Reviewer Report - Tsung-Hui Hu
3 May 2008 Author responded Author comments - Li xiaorong
Resubmission - Version 3
3 May 2008 Submitted Manuscript version 3
6 May 2008 Reviewed Reviewer Report - Tsung-Hui Hu
15 Jul 2008 Author responded Author comments - Li xiaorong
Resubmission - Version 4
15 Jul 2008 Submitted Manuscript version 4
20 Jul 2008 Author responded Author comments - Li xiaorong
Resubmission - Version 5
20 Jul 2008 Submitted Manuscript version 5
Publishing
23 Jul 2008 Editorially accepted
23 Jul 2008 Article published 10.1186/1471-2407-8-205

You can find further information about peer review here.

Back to article page